Demand cancer drugs that truly help patients

susan's picture

Drug regulators and trial designs should assess benefits that actually matter to people with cancer, says Ajay Aggarwal.

Original Source

Main Topic: 
Author: 
Name of the Journal: 
Mark Content Private(Internal): 
Email Alert: 
151
151
Publication Date: 
12/04/2018